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One key to the pathogenic potential of the mycobacteria lies in their capacity to 
resist destruction by infected macrophages and dendritic cells. Robust host immune 
responses during mycobacterial infection often involve a potent CD4, CD8 and gamma 
delta T cell mediated effector responses including lysis of mycobacteria infected host cells, 
secretion of variety of cytokines like IFN-γ etc. However,  pathogenic mycobacteria 
survives for prolonged periods in the phagasomes of infected macrophages within the host 
in an asymptomatic, latent state and can reactivate years later if the host’s immune system 
wanes. One of the most devastating consequences of infection with mycobactreia is the 
formation of caseating granulomas followed by tissue destruction with liquefaction causing 
cavity formation. Pathogenic mycobacteria reside in these granulomas, which are formed by 
the accumulation of monocytes, epithelioid and foamy macrophages as well as cytolytic 
lymphocytes including CD8 T cells around the infection focus. In this regard, rigid balance 
as well as modulation of inflammatory immune responses by the host upon infection of 
pathogenic microbes is one of the crucial steps not only in controlling the spread of 
pathogen from the site of infection to reminder of host organs, but also in mounting an 
effective memory response so that future exposures/infections by similar pathogen can be 
effectively controlled. Significantly, despite this complex host response, it remains unclear, 
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that why the immune response controls mycobacteria but does not eradicate infection. Both 
human and mouse studies have provided ample evidence that even in the face of an 
adequate immune response, mycobacteria are able to persist inside macrophages. These 
findings have suggested series of survival strategies employed by Mycobacterium sp. during 
its infection of host macrophages/dendritic cells which include, blockade of phagosome-
lysosome fusion, secretion of ROI antagonistic proteins like superoxide dismutase & 
catalase, inhibition of processing of its antigens for presentation to T cells, decrease in 
secretion of proinflammatory cytokines by inducing secretion of immunosuppressive 
cytokines like IL-10 and TGF-β etc. 
In view of above-mentioned observations, graulomas in response to pathogenic 
mycobacterial infections have long been considered host-protective structures formed to 
contain infection. In this perspective, Matrix metalloproteinase-9 (MMP-9), an important 
member of Zn2+ and Ca2+ dependent endopeptidases, participates in a significant manner in 
several aspects of host immune responses to mycobacterial infection such as graunloma 
formation, matrix (ECM) reorganization, lymphocytes trafficking and infiltrations, 
inflammation etc. MMP-9 is expressed at various clinical categories of tuberculosis disease 
like active cavitary tuberculosis, meningitis and pleuritis. Notably, in case of pulmonary 
tuberculosis, breakdown of ECM by MMP-9 forms an integral part of the granuloma 
formation. Importantly, Mycobacterium tuberculosis infection in MMP-9 deficient mice 
revealed defective bacterial proliferation, reduced bacterial burden and reduced lung 
macrophages recruitment compared to wild-type, in addition, to reduced ability to initiate or 
maintain well-formed granulomas. In this context, we explored the signaling events 
modulated by Mycobacterium bovis bacillus Calmette-Gue´rin (BCG) or its novel cell wall 
antigens during induced expression of MMP-9 or SPI6 in macrophages. 
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 Our studies clearly demonstrate that NO, a product of iNOS activity, is responsible 
for M. bovis BCG-triggered activation of Notch1 in macrophages through direct regulation 
of Jagged1 expression as well as in generation of activated Notch1. We present the evidence 
that iNOS activity is a critical factor in TLR2 mediated Notch1 activation as macrophages 
derived from iNOS knockout (iNOS-/-), but not from wild-type (WT) mice failed to activate 
Jagged1 expression as well as Notch1 signaling upon M. bovis BCG infection. The loss of 
TLR2-mediated Jagged1 expression or Notch1 activation in iNOS-/- macrophages could be 
rescued by treatment with NO donor 3-morpholinosydnonimine (SIN1) or S-nitroso-
Nacetylpenicillamine (SNAP). Signaling perturbations strongly implicated the role for cross 
talk among members of Notch1-PI3 Kinase and MAPK cascades in M. bovis BCG-TLR2–
mediated activation of Notch1 target genes MMP-9 or Hes1. Chromatin 
immunoprecipitation experiments demonstrate that M. bovis BCG’s ability to trigger 
increased binding of CSL/RBP-Jk to MMP-9 promoter was severely compromised in 
macrophages derived from iNOS-/- mice compared to WT mice. These results are consistent 
with the observation that NO-triggered Notch1 signaling-mediated CSL/RBP-Jk recruitment 
has a positive regulatory role in M. bovis BCG-induced MMP-9 transcription. We show the 
correlative evidence that this mechanism operates in vivo by immunohistochemical 
expression analysis of activated Notch1 or its target gene products Hes1 or MMP-9 in 
brains of WT or iNOS-/- mice that were intracerebrally infected with M. bovis BCG. Further, 
activation of Notch1 signaling in vivo could be demonstrated only in granulomatous lesions 
in brains derived from human patients with tuberculous meningitis (TBM) as opposed to 
healthy individuals, validating the role of Notch1 signaling in mycobacterial pathogenesis. 
Briefly, we have identified NO as the pathological link between TLR2 and Notch1 
signaling, which regulates the relative abundance of various immunopathological 
parameters including MMP-9 in macrophages. 
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Despite mycobacteria elicits robust host T cell responses as well as production of 
NO, ROI or cytokines like interferon-γ (IFN-γ) that are essential for the control of infection, 
the mounted immune response contain, but does not eliminate the infection. These findings 
clearly advocate roles for mycobacteria mediated various immune evasion strategies to 
modulate the signaling cascades thus leading to macrophage activation. Importantly, TLR2 
triggering by mycobacteria elicits the activation of divers sets of anti or pro- apototic genes 
expression, a balance of which will have strong bearing on the overall cell-fate decisions 
across many cell types. In this regard, a novel granzyme B inhibitor, SPI6/PI9, can exhibit 
robust resistance to various cells including dendritic cells or tumor cells from lysis by CD8 
cytotoxic T cells (CTL). SPI6/PI9 predominantly functions by inhibiting Granzyme B, an 
effector protease of cytotoxic granules released by CTL upon its TCR recognition of 
infected cells such as macrophages, dendritic cells etc.  
 In this context, current investigation attempted to investigate molecular details 
involved in M. bovis BCG triggered SPI6 expression as well as the involvement of TLR2-
NO-Notch1 signaling axis in driving induced expression of SPI6, akin to that of MMP-9 
expression. We demonstrate that M. bovis BCG trigger SPI6 expression in macrophages and 
requires critical participation of TLR2-MyD88 dependent NO-Notch1 signaling events. 
More importantly, signaling perturbations data suggest the involvement of cross talk among 
the members of PI3 Kinase and MAPK cascades with Notch1 signaling in SPI6 expression. 
In addition, SPI6 expression requires the Notch1 mediated recruitment of CSL/RBP-Jk and 
NF-κB  to the SPI6 promoter. Functional studies strongly attribute critical involvement of 
SPI6 and MMP-9 in imparting protection to M.bovis BCG infected macrophages from lysis 
effectuated by CTL. 
Macrophages are principal mediators of initiation as well as activation of host 
inflammatory responses to pathogenic mycobacterial infection. Albeit mycobacteria reside 
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within phagolysosomes of the infected macrophages, envelope glycoconjugates like 
Lipoarabinomannan (LAM), phosphatidyl-myo-inositol mannosides (PIM), Trehalose 6,6′-
dimycolate (TDM; cord factor) etc. are released and traffic out of the mycobacterial 
phagosome into endocytic compartments as well as can gain access to the extracellular 
environment in the form of exocytosed vesicles. In this perspective, PIM represent a variety 
of phosphatidyl-myo-inositol mannosides (PIM) 1-6 containing molecules and are integral 
component of the mycobacterial envelope. A number of biological functions have been 
credited to PIM2. PIM2 was shown to trigger TLR2 mediated activation of macrophages 
that resulted in activation of NF-κB, AP-1, and mitogen-activated protein (MAP) kinases. In 
addition to pulmonary granuloma-forming activities, PIM2 was shown to recruit NKT cells 
into granulomas. Further, surface associated PIM was suggested to act as adhesins 
mediating attachment of M. tuberculosis bacilli to non-phagocytic cells. Accordingly, 
mycobacterial envelope antigen PIM2 could initiate or affect the inflammatory responses 
similar to mycobacteria bacilli.  
In this perspective, we explored whether novel cell surface antigen PIM2 similar to 
whole M. bovis BCG bacilli can contribute to molecular signaling events leading to MMP-9 
expression in macrophages. Our current study provides the evidence that PIM2 driven 
activation of signaling cascades triggers the expression of MMP-9. TLR stimulation by 
various agonists has been shown to activate Notch signaling resulting in modulation of 
diverse target genes involved in pro-inflammatory responses in macrophages. In this regard 
we demonstrated that PIM2 induced expression of MMP-9 involved Notch1 upregulation 
and activation of Notch1 signaling pathway in a TLR2-MyD88 manner. Enforced 
expression of the cleaved Notch1 in macrophages induced the expression of MMP-9. 
Further, PIM2 triggered significant p65 nuclear factor-κB (NF-κB) nuclear translocation 
that was dependent on activation of PI3 Kinase or Notch1 signaling. Furthermore, MMP-9 
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expression requires Notch1 mediated recruitment of Suppressor of Hairless (CSL) and NF-
κB to MMP-9 promoter.  
Taken together, our observations clearly describe involvement of TLR2/iNOS in 
activating Notch1 and PI3 Kinase signaling during infection of macrophages with M. bovis 
BCG, thus effectuating the regulation of specific effector gene expressions, such as SPI6 
and MMP-9.  These results clearly describe the cross talk of Notch1 signaling with PI3 
Kinase and MAPK pathways, thus leading to differential effects of Notch1 signaling. 
Overall, we believe that our work will extend the current understanding of inflammatory 
parameters associated with host-mycobacteria interactions which might lead to better design 
as well as evaluation of therapeutic potential of novel agents targeted at diverse 
mycobacterial diseases. 
 
 
 
 
 
 
